Oncology - Bolstering Oral Agent Reporting Related to Distress (ON-BOARD)

McGill University

Status

Completed

Conditions

Oral Chemotherapy

Treatments

Other: Oral chemotherapy information and support

Study type

Interventional

Funder types

Other

Identifiers

NCT04984850

2021-2861

Details and patient eligibility

About

Individuals on oral chemotherapy (OC) often face many challenges requiring adequate informational support, monitoring, and management. This pilot randomized control trial (RCT) aims to assess the feasibility, acceptability, and preliminary effects of a comprehensive OC intervention on medication adherence self-efficacy, medication adherence, and symptom distress.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

18 years of age or older
Diagnosis of cancer, any stage
Being followed by a care team at the affiliated hospital centre
About to start or within the first cycle of oral anticancer treatment (traditional cytotoxic, targeted therapy, hormonal therapy as active ongoing treatment for cancer with the aim of killing cancer cells/shrinking tumor size)
Has a computer/tablet/smartphone device with internet
The ability to communicate, read, and write in English or French

Exclusion criteria

Receiving IV chemotherapy, immunotherapy, and/or oral hormonal therapy as long-term maintenance treatment for prevention of cancer's return/growth of cancer cells after initial treatment
Significant physical or cognitive limitations that would prevent ability to participate in study as reported by patient, primary healthcare provider, or research staff
At imminent "end-of-life"
Participating in an ongoing clinical trial